Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

NCT00425815 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study terminated at Sponsor's request.

Conditions

Schizophrenia

Interventions

DRUG: Org 24448
OTHER: Placebo

Sponsor

University of California, Los Angeles

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]